Baumgartner, H., Falk, V., Bax, J.J., et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38 (2017), 2739–2791.
Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 135 (2017), e1159–e1195.
Unger, P., Pibarot, P., Tribouilloy, C., et al. Multiple and Mixed Valvular Heart Diseases. Circ Cardiovasc Imaging, 11, 2018, e007862.
Reid, C.L., Anton-Culver, H., Yunis, C., Gardin, J.M., Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol 99 (2007), 830–834.
Singh, J.P., Evans, J.C., Levy, D., et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83 (1999), 897–902.
Pai, R.G., Varadarajan, P., Prognostic implications of mitral regurgitation in patients with severe aortic regurgitation. Circulation 122 (2010), S43–S47.
Andell, P., Li, X., Martinsson, A., et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart 103 (2017), 1696–1703.
Iung, B., Baron, G., Tornos, P., Gohlke-Barwolf, C., Butchart, E.G., Vahanian, A., Valvular heart disease in the community: a European experience. Curr Probl Cardiol 32 (2007), 609–661.
Cutter, D.J., Schaapveld, M., Darby, S.C., et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst, 2015, 107.
Tribouilloy, C., Marechaux, S., Jobic, Y., et al. Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study. Eur Heart J 34 (2013), 3580–3587.
Lopez, J., Revilla, A., Vilacosta, I., et al. Multiple-valve infective endocarditis: clinical, microbiologic, echocardiographic, and prognostic profile. Medicine (Baltimore) 90 (2011), 231–236.
Beaudoin, J., Handschumacher, M.D., Zeng, X., et al. Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle. J Am Coll Cardiol 61 (2013), 1809–1816.
Lim, J.Y., Jung, S.H., Kim, J.B., et al. Management of concomitant mild to moderate functional mitral regurgitation during aortic valve surgery for severe aortic insufficiency. J Thorac Cardiovasc Surg 148 (2014), 441–446.
Wisenbaugh, T., Spann, J.F., Carabello, B.A., Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol 3 (1984), 916–923.
Carabello, B.A., Is it ever too late to operate on the patient with valvular heart disease?. J Am Coll Cardiol 44 (2004), 376–383.
Gentles, T.L., Finucane, A.K., Remenyi, B., Kerr, A.R., Wilson, N.J., Ventricular function before and after surgery for isolated and combined regurgitation in the young. Ann Thorac Surg 100 (2015), 1383–1389.
Niles, N., Borer, J.S., Kamen, M., Hochreiter, C., Devereux, R.B., Kligfield, P., Preoperative left and right ventricular performance in combined aortic and mitral regurgitation and comparison with isolated aortic or mitral regurgitation. Am J Cardiol 65 (1990), 1372–1378.
Zoghbi, W.A., Adams, D., Bonow, R.O., et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr 30 (2017), 303–371.
Hundley, W.G., Bluemke, D.A., Finn, J.P., et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 121 (2010), 2462–2508.
Cawley, P.J., Maki, J.H., Otto, C.M., Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation 119 (2009), 468–478.
Alashi, A., Mentias, A., Abdallah, A., et al. Incremental prognostic utility of left ventricular global longitudinal strain in asymptomatic patients with significant chronic aortic regurgitation and preserved left ventricular ejection fraction. JACC Cardiovasc Imaging 11 (2018), 673–682.
Thomas, J.D., Kinno, M., The Prognostic Role of Global Longitudinal Strain in Severe Primary Mitral Regurgitation: Moving Past the Proof-of-Concept Era. JACC Cardiovasc Imaging 11 (2018), 1245–1247.
Skudicky, D., Essop, M.R., Sareli, P., Time-related changes in left ventricular function after double valve replacement for combined aortic and mitral regurgitation in a young rheumatic population. Predictors of postoperative left ventricular performance and role of chordal preservation. Circulation 95 (1997), 899–904.
Iung, B., Baron, G., Butchart, E.G., et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24 (2003), 1231–1243.
Vassileva, C.M., Li, S., Thourani, V.H., et al. Outcome characteristics of multiple-valve surgery: comparison with single-valve procedures. Innovations (Phila) 9 (2014), 27–32.
Cannegieter, S.C., Rosendaal, F.R., Wintzen, A.R., van der Meer, F.J., Vandenbroucke, J.P., Briet, E., Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 333 (1995), 11–17.
Une, D., Mesana, L., Chan, V., et al. Clinical impact of changes in left ventricular function after aortic valve replacement: analysis from 3112 patients. Circulation 132 (2015), 741–747.
Essop, M.R., Wisenbaugh, T.W., Sareli, P.E., Discordant changes in left ventricular performance after valve replacement for isolated rheumatic mitral regurgitation versus combined mitral and aortic regurgitation in teenagers. Am J Cardiol 73 (1994), 910–914.
Coutinho, G.F., Martinez Cereijo, J.M., Correia, P.M., et al. Long-term results after concomitant mitral and aortic valve surgery: repair or replacement?. Eur J Cardiothorac Surg 54 (2018), 1085–1092.
Gillinov, A.M., Blackstone, E.H., Cosgrove, D.M.3rd, et al. Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg 125 (2003), 1372–1387.
Hamamoto, M., Bando, K., Kobayashi, J., et al. Durability and outcome of aortic valve replacement with mitral valve repair versus double valve replacement. Ann Thorac Surg 75 (2003), 28–33 [discussion -4].
Leavitt, B.J., Baribeau, Y.R., DiScipio, A.W., et al. Outcomes of patients undergoing concomitant aortic and mitral valve surgery in northern New England. Circulation 120 (2009), S155–S162.
Gillinov, A.M., Blackstone, E.H., White, J., et al. Durability of combined aortic and mitral valve repair. Ann Thorac Surg 72 (2001), 20–27.
Lim, G.B., Benefit of the MitraClip for mitral regurgitation. Nat Rev Cardiol, 15, 2018, 728.
Haddad, A., Arwani, R., Altayar, O., Sawas, T., Murad, M.H., de Marchena, E., Transcatheter aortic valve replacement in patients with pure native aortic valve regurgitation: A systematic review and meta-analysis. Clin Cardiol 42 (2019), 159–166.
Ando, T., Takagi, H., Briasoulis, A., et al. A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions. Catheter Cardiovasc Interv 91 (2018), 124–134.
Gerosa, G., D'Onofrio, A., Manzan, E., et al. One-stage off-pump transapical mitral valve repair and aortic valve replacement. Circulation 131 (2015), e430–e434.